Pick's disease is associated with mutations in the tau gene

Recently, mutations within the tau gene have been associated with some familial forms of frontotemporal dementia. To investigate whether tau gene mutations are also associated with Pick's disease, we analyzed the tau gene in 30 cases of pathologically confirmed Pick's disease. Two coding mutations were identified in separate cases of Pick's disease. A glycine‐to‐arginine mutation at codon 389 was detected in 1 case and a lysine‐to‐threonine mutation at codon 257 was identified in another. Analysis of dephosphorylated tau from the brain of the patient with the codon 389 mutation revealed a prominent band representing tau, with four microtubule‐binding domains and no amino terminal inserts. This is in contrast to Pick's disease without any tau gene mutations, which consist of tau with mainly three microtubule‐binding domains and only a trace of tau, with four microtubule‐binding domains. Functional analysis of tau with these two mutations demonstrated a reduced ability of tau to promote microtubule assembly. Surprisingly, these mutations increased tau's susceptibility to calpain I digestion, suggesting that this feature may be related to the formation of a Pick type of histology. Moreover, these data suggest that Pick's disease is not a separate entity but part of the frontotemporal dementia disease spectrum. Ann Neurol 2000;48:859–867

[1]  M. Guazzelli,et al.  Tau gene mutation G389R causes a tauopathy with abundant pick body-like inclusions and axonal deposits. , 1999, Journal of neuropathology and experimental neurology.

[2]  M. Hutton,et al.  FTDP‐17 tau mutations decrease the susceptibility of tau to calpain I digestion , 1999, FEBS letters.

[3]  M G Spillantini,et al.  Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. , 1999, Journal of neuropathology and experimental neurology.

[4]  John X. Morris,et al.  Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.

[5]  W. Blackstock,et al.  New Phosphorylation Sites Identified in Hyperphosphorylated Tau (Paired Helical Filament‐Tau) from Alzheimer's Disease Brain Using Nanoelectrospray Mass Spectrometry , 1998, Journal of neurochemistry.

[6]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[7]  W. Kamphorst,et al.  Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau. , 1998, The American journal of pathology.

[8]  M. Goedert,et al.  Tau proteins with FTDP‐17 mutations have a reduced ability to promote microtubule assembly , 1998, FEBS letters.

[9]  A Klug,et al.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Ronald C. Petersen,et al.  Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.

[11]  G. Schellenberg,et al.  Tau is a candidate gene for chromosome 17 frontotemporal dementia , 1998, Annals of neurology.

[12]  A. Delacourte,et al.  Vulnerable neuronal subsets in Alzheimer's and Pick's disease are distinguished by their τ isoform distribution and phosphorylation , 1998, Annals of neurology.

[13]  A. Kertesz Frontotemporal dementia, Pick disease, and corticobasal degeneration. One entity or 3? 1. , 1997, Archives of neurology.

[14]  D. Neary Frontotemporal degeneration, Pick disease, and corticobasal degeneration. One entity or 3? 3. , 1997, Archives of neurology.

[15]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[16]  J. Ahringer,et al.  PTL-1, a microtubule-associated protein with tau-like repeats from the nematode Caenorhabditis elegans. , 1996, Journal of cell science.

[17]  D. Neary,et al.  Dementia of frontal lobe type: neuropathology and immunohistochemistry. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[18]  D. Dickson,et al.  Heterogeneity of tau proteins in Alzheimer's disease. Evidence for increased expression of an isoform and preferential distribution of a phosphorylated isoform in neurites. , 1993, The American journal of pathology.

[19]  P Brown,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. , 1992, Science.

[20]  K. Titani,et al.  Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. , 1992, The Journal of biological chemistry.